Outcomes Improved with Individualized Care Guided
by BVA-100
Peer-reviewed study in the Journal of the American College of Cardiology – Heart Failure
N = 245
56% reduction in 30-day readmissions
82% reduction in 30-day mortality
86% reduction in 365-day mortality
62% identified as anemic
“Blood volume analysis offers providers a unique opportunity to reduce heart failure readmissions and mortality in both the HFpEF and HFrEF populations. We have used the technology at our center extensively and have found it to be hugely informative and cost-effective.“
John Jefferies M.D., MPH, FACC, FAHA, FAAP, FHFSA, FRCPE
Chen J, Normand S-LT, Wang Y, et al. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries: 1998-2008. J Am Med Assoc 2011;306:1669-78.
Heidenreich et al. Forecasting the Future of Cardiovascular Disease in the United States. A Policy Statement from the American Heart Association. Circulation. 2011;123:933-944.
2013 ACCF/AHA Guideline for the Management of Heart Failure, JACC Vol. 62, No. 16, 2013.
https://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_heart_failure.htm